Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Testosterone topical - AbbVie/Besins/Mylan

Next Previous
Drug Profile

Testosterone topical - AbbVie/Besins/Mylan

Alternative Names: 1% Testosterone gel (AndroGel) - AbbVie; 1.62% Testosterone gel - Solvay; AndroGel; AndroGel PD; Testogel; Testosterone topical - Abbott

Latest Information Update: 04 Nov 2018

Price : $50 *
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Besins International; Unimed Pharmaceuticals
  • Developer AbbVie; Besins Healthcare; Solvay
  • Class Anabolic steroids; Androstenols; Erectile dysfunction therapies; Hormonal replacements; Small molecules; Testosterone congeners
  • Mechanism of Action Androgen receptor agonists; Growth stimulants; Testosterone congener stimulants; Testosterone replacements
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Marketed Hypogonadism
  • Discontinued Growth disorders

Most Recent Events

  • 07 Aug 2018 Solvay Pharmaceuticals completes a phase I trial in Hypogonadism in USA (Topical) (NCT00425568)
  • 04 Feb 2016 No recent reports on development identified - Phase-III for Hypogonadism in China (Topical)
  • 02 Sep 2015 First Generic equivalent available in USA for Hypogonadism
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Legal

Back to top